This review outlines the diagnostic and therapeutic challenges across the continuum of growth hormone-IGF-I axis defects causing short stature.
The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.
Building similarity graph...
Analyzing shared references across papers
Loading...
Clinical Endocrinology
Oregon Health & Science University
William Harvey Research Institute
Bristol Royal Hospital for Children
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Savage et al. (Tue,) studied this question.